287 related articles for article (PubMed ID: 25096602)
1. Strategies to predict rheumatoid arthritis development in at-risk populations.
Karlson EW; van Schaardenburg D; van der Helm-van Mil AH
Rheumatology (Oxford); 2016 Jan; 55(1):6-15. PubMed ID: 25096602
[TBL] [Abstract][Full Text] [Related]
2. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis.
Petrovská N; Prajzlerová K; Vencovský J; Šenolt L; Filková M
Autoimmun Rev; 2021 May; 20(5):102797. PubMed ID: 33746022
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in inflammatory arthritis.
Conigliaro P; Chimenti MS; Triggianese P; Sunzini F; Novelli L; Perricone C; Perricone R
Autoimmun Rev; 2016 Jul; 15(7):673-83. PubMed ID: 26970491
[TBL] [Abstract][Full Text] [Related]
4. How to investigate: Pre-clinical rheumatoid arthritis.
Martins P; Fonseca JE
Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101438. PubMed ID: 31627994
[TBL] [Abstract][Full Text] [Related]
5. Predicting Rheumatoid Arthritis in At-risk Individuals.
van Boheemen L; van Schaardenburg D
Clin Ther; 2019 Jul; 41(7):1286-1298. PubMed ID: 31196647
[TBL] [Abstract][Full Text] [Related]
6. A prediction rule for the development of arthritis in seropositive arthralgia patients.
van de Stadt LA; Witte BI; Bos WH; van Schaardenburg D
Ann Rheum Dis; 2013 Dec; 72(12):1920-6. PubMed ID: 23178208
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
8. Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.
van Steenbergen HW; van Nies JA; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
Arthritis Res Ther; 2014 Apr; 16(2):R92. PubMed ID: 24721160
[TBL] [Abstract][Full Text] [Related]
9. Pre-RA: Can early diagnosis lead to prevention?
Haville S; Deane KD
Best Pract Res Clin Rheumatol; 2022 Mar; 36(1):101737. PubMed ID: 34991984
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis.
Sparks JA; Karlson EW
Curr Rheumatol Rep; 2016 Mar; 18(3):15. PubMed ID: 26951253
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis.
Brulhart L; Alpízar-Rodríguez D; Nissen MS; Zufferey P; Ciubotariu I; Fleury G; Lazarou I; Gabay C; Finckh A
RMD Open; 2019; 5(2):e000922. PubMed ID: 31565240
[TBL] [Abstract][Full Text] [Related]
12. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation.
Deane KD; Norris JM; Holers VM
Rheum Dis Clin North Am; 2010 May; 36(2):213-41. PubMed ID: 20510231
[TBL] [Abstract][Full Text] [Related]
13. Preclinical rheumatoid arthritis (autoantibodies): an updated review.
Deane KD
Curr Rheumatol Rep; 2014 May; 16(5):419. PubMed ID: 24643396
[TBL] [Abstract][Full Text] [Related]
14. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
Young KA; Deane KD; Derber LA; Hughes-Austin JM; Wagner CA; Sokolove J; Weisman MH; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Robinson WH; Holers VM; Norris JM
Arthritis Rheum; 2013 Aug; 65(8):1995-2004. PubMed ID: 23754702
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.
Sokolove J; Bromberg R; Deane KD; Lahey LJ; Derber LA; Chandra PE; Edison JD; Gilliland WR; Tibshirani RJ; Norris JM; Holers VM; Robinson WH
PLoS One; 2012; 7(5):e35296. PubMed ID: 22662108
[TBL] [Abstract][Full Text] [Related]
16. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.
Kolfenbach JR; Deane KD; Derber LA; O'Donnell C; Weisman MH; Buckner JH; Gersuk VH; Wei S; Mikuls TR; O'Dell J; Gregersen PK; Keating RM; Norris JM; Holers VM
Arthritis Rheum; 2009 Dec; 61(12):1735-42. PubMed ID: 19950324
[TBL] [Abstract][Full Text] [Related]
17. Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.
Alpizar-Rodriguez D; Mueller RB; Möller B; Dudler J; Ciurea A; Zufferey P; Kyburz D; Walker UA; von Mühlenen I; Roux-Lombard P; Mahler M; Lamacchia C; Courvoisier DS; Gabay C; Finckh A
Rheumatology (Oxford); 2017 Sep; 56(9):1579-1585. PubMed ID: 28859327
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention.
O'Neil LJ; Alpízar-Rodríguez D; Deane KD
J Rheumatol; 2024 Apr; 51(4):337-349. PubMed ID: 38224993
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
Alpizar-Rodriguez D; Brulhart L; Mueller RB; Möller B; Dudler J; Ciurea A; Walker UA; Von Mühlenen I; Kyburz D; Zufferey P; Mahler M; Bas S; Gascon D; Lamacchia C; Roux-Lombard P; Lauper K; Nissen MJ; Courvoisier DS; Gabay C; Finckh A
Clin Rheumatol; 2017 Mar; 36(3):677-682. PubMed ID: 28110385
[TBL] [Abstract][Full Text] [Related]
20. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.
Yarwood A; Huizinga TW; Worthington J
Rheumatology (Oxford); 2016 Feb; 55(2):199-209. PubMed ID: 25239882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
